The American Society of Hematology (ASH) announced a $3 million annual commitment to funding blood diseases via its ASH Bridge Grant program that started in 2012 as a short-term pilot study to support researchers affected by federal funding shortfalls.
“The ASH Bridge Grants program encourages the retention of promising researchers in the field of hematology, prevents research labs from closing, and most importantly, ensures that research and discovery can continue,” said ASH President Charles S. Abrams, MD. “It is our hope that Washington’s recent willingness to work across the aisle continues with increased investment in the NIH. Such funding is paramount to ensuring that the end to blood cancers and blood disease are discovered in labs across the country, and that those who are dependent upon these cures will see them in their lifetimes.”
ASH also announced the following nine investigators who have received the latest round of ASH Bridge Grants:
- Jaehyung Cho, PhD, University of Illinois, Chicago, IL
- Clark W. Distelhorst, MD, Case Western Reserve University School of Medicine, Cleveland, OH
- Siegfried Janz, MD, DSc, University of Iowa Carver College of Medicine, Iowa City, IA
- Ann Mullally, MD, The Brigham and Women’s Hospital, Boston, MA
- Enrico Novelli, MD, University of Pittsburgh, Pittsburgh, PA
- Samir Parekh, MD, Icahn School of Medicine at Mount Sinai, New York, NY
- Zhijian Qian, PhD, University of Illinois, Chicago, IL
- Matthew Riese, MD, PhD, BloodCenter of Wisconsin, Milwaukee, WI
- Fenghuang Zhan, MD, PhD, University of Iowa, Iowa City, IA
Source: American Society of Hematology press release, July 21, 2016.